Thomas J Galletta

5PUBLICATIONS
12CO-AUTHORS
AutoimmunityCancer geneticsMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Respiratory diseases
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 15, 2026
Emapalumab for Immune Effector Cell-Associated Hemophagocytic Lymphohistiocytosis-Like Syndrome Following CD19-Directed CAR-T in Two Patients With B-ALL: Clinical and Biomarker Correlates.

|Nov 28, 2025
Metabolic reprogramming in Fanconi anemia: Evidence of compromised glucose oxidation, enhanced ketogenesis, and metabolic inflexibility.

Sara Vicente-Muñoz, Suzanne S Summer, Thomas J Galletta

|May 20, 2025
Elevated Bromide Levels Due to Tazemetostat Therapy Treated With Salt and Water Supplementation in Two Children With Atypical Teratoid Rhabdoid Tumor.

Thomas J Galletta, Stefanie W Benoit, Justin Markham

|Feb 23, 2023
Durable remissions achieved with reinfusion of CD19-directed CAR-T despite failure to induce or maintain B-cell aplasia and single-center experience with reinfusion of tisagenlecleucel.

Thomas J Galletta, Jeremy D Rubinstein, Christa Krupski

|Mar 07, 2022
Coronavirus disease 2019 and vaccination in patients with Shwachman-Diamond syndrome.

Thomas J Galletta, Sara K Loveless, Maggie M Malsch

Pageof 1

Frequent Collaborators

2 joint publications

Jeremy D Rubinstein

2 joint publications

Christopher E Dandoy

1 joint publications

Akiko Shimamura

1 joint publications

Kasiani C Myers